{"id":"https://openalex.org/W2767800486","doi":"https://doi.org/10.1161/cir.0000000000000551","title":"American Heart Association Principles on the Accessibility and Affordability of Drugs and Biologics","display_name":"American Heart Association Principles on the Accessibility and Affordability of Drugs and Biologics","publication_year":2017,"publication_date":"2017-11-09","ids":{"openalex":"https://openalex.org/W2767800486","doi":"https://doi.org/10.1161/cir.0000000000000551","mag":"2767800486","pmid":"https://pubmed.ncbi.nlm.nih.gov/29122813"},"language":"en","primary_location":{"id":"doi:10.1161/cir.0000000000000551","doi":"https://doi.org/10.1161/cir.0000000000000551","is_oa":true,"landing_page_url":"https://doi.org/10.1161/cir.0000000000000551","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000551","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000551","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019612250","display_name":"Elliott Marshall Antman","orcid":"https://orcid.org/0000-0002-0808-9199","observed_orcids":["https://orcid.org/0000-0002-0808-9199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elliott M. Antman","raw_affiliation_strings":["Elliott M. Antman"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elliott M. Antman","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056183044","display_name":"Mark A. Creager","orcid":"https://orcid.org/0000-0001-9758-6447","observed_orcids":["https://orcid.org/0000-0001-9758-6447"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark A. Creager","raw_affiliation_strings":["Mark A. Creager"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mark A. Creager","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067892109","display_name":"Steven R. Houser","orcid":"https://orcid.org/0000-0001-6359-5425","observed_orcids":["https://orcid.org/0000-0001-6359-5425"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven R. Houser","raw_affiliation_strings":["Steven R. Houser"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steven R. Houser","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023130708","display_name":"John J. Warner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John J. Warner","raw_affiliation_strings":["John J. Warner"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John J. Warner","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009283466","display_name":"Madeleine Konig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Madeleine Konig","raw_affiliation_strings":["Madeleine Konig"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Madeleine Konig","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.094,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.39622642,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"136","issue":"24","first_page":"e441","last_page":"e447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-affordability","display_name":"drug affordability","score":0.7570000290870667},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.8610000014305115},{"id":"https://openalex.org/keywords/pharmaceutical-spending","display_name":"pharmaceutical spending","score":0.718999981880188},{"id":"https://openalex.org/keywords/biologics","display_name":"biologics","score":0.7279999852180481},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.9089999794960022},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":1.0},{"id":"https://openalex.org/keywords/cardiovascular-drugs","display_name":"cardiovascular drugs","score":0.5239999890327454},{"id":"https://openalex.org/keywords/patient-advocacy","display_name":"patient advocacy","score":0.5170000195503235},{"id":"https://openalex.org/keywords/health-policy","display_name":"health policy","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.892034649848938},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.8771957159042358},{"id":"https://openalex.org/C2776473838","wikidata":"https://www.wikidata.org/wiki/Q174165","display_name":"Innovator","level":3,"score":0.7495205402374268},{"id":"https://openalex.org/C2776643233","wikidata":"https://www.wikidata.org/wiki/Q1414593","display_name":"Patient Protection and Affordable Care Act","level":4,"score":0.49406126141548157},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.44465214014053345},{"id":"https://openalex.org/C2988170871","wikidata":"https://www.wikidata.org/wiki/Q11000047","display_name":"Healthcare system","level":3,"score":0.410689115524292},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3941786289215088},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3909105956554413},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.26691675186157227},{"id":"https://openalex.org/C2983635472","wikidata":"https://www.wikidata.org/wiki/Q334911","display_name":"Health insurance","level":3,"score":0.23415395617485046},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.21124818921089172},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.12278139591217041},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10682505369186401},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C84309077","wikidata":"https://www.wikidata.org/wiki/Q3908516","display_name":"Entrepreneurship","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000572","descriptor_name":"American Heart Association","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006297","descriptor_name":"Health Services Accessibility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055317","descriptor_name":"Evidence-Based Practice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1161/cir.0000000000000551","doi":"https://doi.org/10.1161/cir.0000000000000551","is_oa":true,"landing_page_url":"https://doi.org/10.1161/cir.0000000000000551","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000551","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:29122813","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29122813","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1161/cir.0000000000000551","doi":"https://doi.org/10.1161/cir.0000000000000551","is_oa":true,"landing_page_url":"https://doi.org/10.1161/cir.0000000000000551","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000551","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6240000128746033}],"sustainable_development_goals_aurora":[{"display_name":"Partnerships for the goals","id":"https://metadata.un.org/sdg/17","score":0.44999998807907104}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2767800486.pdf","grobid_xml":"https://content.openalex.org/works/W2767800486.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W114208993","https://openalex.org/W324102958","https://openalex.org/W849320553","https://openalex.org/W2044439361","https://openalex.org/W2046426458","https://openalex.org/W2067032911","https://openalex.org/W2072727975","https://openalex.org/W2152274383","https://openalex.org/W2159179436","https://openalex.org/W2237633597","https://openalex.org/W2273267066","https://openalex.org/W2326662527","https://openalex.org/W2413636075","https://openalex.org/W2513403311","https://openalex.org/W2611064734","https://openalex.org/W2735789192","https://openalex.org/W3125730391"],"related_works":["https://openalex.org/W3209742118","https://openalex.org/W3204949767","https://openalex.org/W4416021606","https://openalex.org/W107316637","https://openalex.org/W3125084821","https://openalex.org/W2579920460","https://openalex.org/W4411516343","https://openalex.org/W2211307951","https://openalex.org/W2774823352","https://openalex.org/W4308032353"],"abstract_inverted_index":{"Net":[0],"US":[1],"spending":[2],"on":[3],"pharmaceuticals":[4],"reached":[5],"$309.5":[6],"billion":[7,26],"in":[8,74,143,172],"2015,":[9],"an":[10,121],"8.5%":[11],"increase":[12,73],"from":[13],"the":[14,52,77,99,129,135],"year":[15],"before,":[16],"and":[17,24,31,43,50,55,67,88,112,117,153],"is":[18],"expected":[19],"to":[20,57,65,98,127,155,160],"reach":[21],"between":[22],"$370":[23],"$400":[25],"by":[27,38],"2020.":[28],"These":[29],"current":[30],"projected":[32],"levels":[33,92],"have":[34,114],"raised":[35],"serious":[36],"concerns":[37],"policy":[39],"makers,":[40],"providers,":[41],"payers,":[42],"patient":[44,123],"groups":[45],"that":[46,93,149,167],"they":[47],"are":[48,90,150],"unsustainable":[49],"threaten":[51],"affordability":[53],"of":[54,81,132,165,174],"accessibility":[56],"much-needed":[58],"therapies":[59],"for":[60,104,145],"patients.":[61,156],"Two":[62],"trends":[63],"related":[64],"drugs/biologics":[66],"generic":[68,107],"drugs/biosimilars":[69],"underlie":[70],"this":[71,175],"overall":[72],"spending.":[75],"First,":[76],"market":[78],"entry":[79],"prices":[80,103],"innovator":[82],"pharmaceutical":[83],"products,":[84],"or":[85],"brand":[86],"drugs":[87,108],"biologics,":[89],"at":[91],"some":[94,105],"assessments":[95],"consider":[96],"unaffordable":[97],"healthcare":[100],"system.":[101],"Second,":[102],"established":[106],"such":[109],"as":[110],"digoxin":[111],"captopril":[113],"seen":[115],"sharp":[116],"rapid":[118],"increases.":[119],"As":[120],"evidence-based":[122],"advocacy":[124],"organization":[125],"dedicated":[126],"improving":[128],"cardiovascular":[130],"health":[131],"all":[133],"Americans,":[134],"American":[136],"Heart":[137],"Association":[138],"has":[139],"a":[140,163],"unique":[141],"role":[142],"advocating":[144],"treatments,":[146],"including":[147],"medicines":[148],"available,":[151],"affordable,":[152],"accessible":[154],"This":[157],"advisory":[158],"serves":[159],"lay":[161],"out":[162],"set":[164],"principles":[166],"will":[168],"guide":[169],"association":[170],"engagement":[171],"pursuit":[173],"goal.":[176]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-11-17T00:00:00"}